615 related articles for article (PubMed ID: 25180292)
1. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
[TBL] [Abstract][Full Text] [Related]
3. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
[TBL] [Abstract][Full Text] [Related]
5. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
6. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
Wei J; Ghosh AK; Chu H; Fang F; Hinchcliff ME; Wang J; Marangoni RG; Varga J
Arthritis Rheumatol; 2015 May; 67(5):1323-34. PubMed ID: 25707573
[TBL] [Abstract][Full Text] [Related]
7. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.
Mallano T; Palumbo-Zerr K; Zerr P; Ramming A; Zeller B; Beyer C; Dees C; Huang J; Hai T; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):586-92. PubMed ID: 25589515
[TBL] [Abstract][Full Text] [Related]
8. S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Avouac J; Dees C; Sumova B; Distler A; Beyer C; Cerezo LA; Becvar R; Distler O; Grigorian M; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2015 Sep; 74(9):1748-55. PubMed ID: 24709861
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.
Beyer C; Zenzmaier C; Palumbo-Zerr K; Mancuso R; Distler A; Dees C; Zerr P; Huang J; Maier C; Pachowsky ML; Friebe A; Sandner P; Distler O; Schett G; Berger P; Distler JH
Ann Rheum Dis; 2015 Jul; 74(7):1408-16. PubMed ID: 24567525
[TBL] [Abstract][Full Text] [Related]
12. Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.
Palumbo-Zerr K; Soare A; Zerr P; Liebl A; Mancuso R; Tomcik M; Sumova B; Dees C; Chen CW; Wohlfahrt T; Mallano T; Distler A; Ramming A; Gelse K; Mihai C; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2017 Jan; 76(1):244-251. PubMed ID: 27113414
[TBL] [Abstract][Full Text] [Related]
13. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosis.
Palumbo K; Zerr P; Tomcik M; Vollath S; Dees C; Akhmetshina A; Avouac J; Yaniv M; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2011 Jul; 70(7):1320-6. PubMed ID: 21515915
[TBL] [Abstract][Full Text] [Related]
16. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
Liang R; Kagwiria R; Zehender A; Dees C; Bergmann C; Ramming A; Krasowska D; Michalska-Jakubus M; Kreuter A; Kraner ME; Schett G; Distler JHW
Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
[TBL] [Abstract][Full Text] [Related]
17. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
Zhang Y; Pötter S; Chen CW; Liang R; Gelse K; Ludolph I; Horch RE; Distler O; Schett G; Distler JHW; Dees C
Ann Rheum Dis; 2018 May; 77(5):744-751. PubMed ID: 29431122
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
20. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
